Delivery Order SPE2DR25D2009-SPE2DR26FJ4W9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,147.44 to AmerisourceBergen Drug Corp for the supply of ENGERIX-B 20 MCG/ML vaccine product. This firm fixed-price, competitively awarded contract was executed on October 22, 2025, with an ultimate completion date of October 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $10,083.90 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine on January 6, 2026, with completion expected by January 7, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems,...
- The Defense Logistics Agency awarded a $1,080.34 delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine, with performance at the company's Conshohocken, Pennsylvania location. This non-competitive, firm fixed-price delivery order was issued on December 2, 2025, with an ultimate completion date of December 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfilled this order under its existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of ENGERIX-B 20 MCG/ML (a hepatitis B vaccine) with a ceiling value of $1,422.15. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of December 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award leverages AmerisourceBergen's extensive pharmaceutical distribution...
- The Defense Logistics Agency awarded a delivery order valued at $1,359.98 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine (hepatitis B vaccine) on September 22, 2025, with completion targeted for September 23, 2025. This competitively awarded, firm fixed-price delivery order was placed without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $1,040.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for ENGERIX-B 20 MCG/ML vaccine supply. This competitive award, with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $23,307.87 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on November 5, 2025, with completion expected by November 6, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine supply, valued at $18,567.90 under a firm fixed price structure. This non-set-aside award was executed on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,751.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for ENGERIX-B 20 MCG/ML vaccine syringes. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for ENGERIX-B 20 MCG/ML Vial pharmaceutical product with a ceiling value of $1,717.48. This non-competitive delivery order, utilizing firm fixed price terms, is scheduled for completion by December 8, 2025, and will be performed at the awardee's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ4W9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of ENGERIX-B 20 MCG/ML vaccine at a firm fixed price of $1,727.74. This non-set-aside delivery order, which is expected to be completed by January 8, 2026, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive contract portfolio with the Defense Logistics Agency demonstrates its capability to deliver a wide range of pharmaceutical products and medical supplies, including vaccines, specialty medications, and medical devices across multiple therapeutic domains. This delivery order for the hepatitis B vaccine supports the Defense Health Agency and other federal healthcare systems' immunization requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 1/6/26 |